Last reviewed · How we verify
No price
No price is a Small molecule drug developed by Hadassah Medical Organization. It is currently in Phase 1 development.
No Price is a study that aims to increase the uptake of Long-acting Reversible Contraceptives (LARCs) in Cameroon through a randomized-controlled trial. The study compares the effectiveness of sequential versus simultaneous recommendations for LARC uptake, with price discounts being one of the interventions used.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | No price |
|---|---|
| Sponsor | Hadassah Medical Organization |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effects of Tobacco Abuse Liability-dependent Taxes in the ETM (NA)
- An Experimental Evaluation of Menthol-Flavored Tobacco Accessories (NA)
- Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives (NA)
- Supermarket Labelling and Taxation Study (NA)
- PRICE vs PEACE and LOVE in Adolescent Lateral Ankle Sprain Rehabilitation (NA)
- Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2 (NA)
- Mobile Food Market Cluster Randomized Trial (NA)
- Harambee: Integrated Community-based HIV/NCD Care & Microfinance Groups in Kenya (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- No price CI brief — competitive landscape report
- No price updates RSS · CI watch RSS
- Hadassah Medical Organization portfolio CI
Frequently asked questions about No price
What is No price?
Who makes No price?
What development phase is No price in?
Related
- Manufacturer: Hadassah Medical Organization — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing